Page 196 - Basic Monitoring in Canine and Feline Emergency Patients
P. 196

For cases of suspected individual factor deficien-  ‘global’ overview  of hemostasis combined  with
            cies, such as hemophilia, the activity levels of spe-  graphical outputs that allow for quick visual assess-
  VetBooks.ir  cific coagulation factors can also be measured. This   ment of results has made this form of testing grow
                                                         in popularity in recent years. Viscoelastic testing is
            is done by mixing the patient’s plasma with test
            plasma that is known to be deficient in the specific
                                                         medicine and veterinary referral institutions.
            clotting factor of interest. A PT or aPTT (depend-  becoming more widely available in both human
            ing on location of the factor of interest in the   In general, when performing viscoelastic testing,
            intrinsic or extrinsic cascade) is performed on the   citrated whole blood is incubated in a chamber
            pooled plasma sample. The degree of prolongation   with calcium plus some form of activator (ellagic
            of either PT or aPTT is used to extrapolate the   acid, TF, etc.). As the blood clots, the chamber will
            activity of the coagulation factor of interest. While   be physically affected in some way depending on
            these tests may not be readily available for the   the methodology of  the  specific analyzer. For
            acutely  bleeding  animal  who  is  likely  emergently   example, in the  TEG, the changes in rotational
            receiving fresh frozen plasma or whole blood (see   force applied to a pin within the chamber by the
            Section 9.4), sample collection prior to administra-  clotting blood is measured (e.g. initially the pin
            tion of blood products can be analyzed at a later   moves freely but its movement slows and changes
            time for a definitive diagnosis. For stable patients,   as the blood clots). The signal from the chamber is
            screening for specific factor activities can help pre-  translated into a characteristic tracing. Several vari-
            surgical planning for elective procedures and   ables can be measured from this tracing which rep-
            inform breeding decisions.                   resent various aspects of clot formation speed, clot
                                                         strength, and rate of clot breakdown.  While the
                                                         entire viscoelastic assay may run for 60–90 min-
            Fibrin degradation products
                                                         utes, the early physical appearance of the tracing as
            Measurement of elevations of components such as   well as many of the variables are often apparent
            FDPs may indicate pro-thrombotic and procoagu-  within 10–20 minutes of initiation of the test.
            lant  states  such  as  disseminated  intravascular   Please see Further Reading section for more infor-
            coagulation. Fibrin degradation products are   mation on viscoelastic testing and interpretation of
            formed from the breakdown of fibrinogen, fibrin,   the various parameters.
            or crosslinked fibrin. Elevated d-dimers, which are
            a subtype of FDPs created only by breakdown of   9.3  Indications
            actual thrombi (i.e. crosslinked fibrin formed in the
            amplification and propagation phases, see Fig. 9.4),   In general, coagulation testing is pursued in
            are more sensitive and specific for the diagnosis of   response to the clinical presentation of the animal.
            thrombosis. Both FDP and d-dimer assays are typ-  Clinical clues can guide the clinician to a suspicion
            ically performed by semi-quantitative latex agglu-  of either a primary or a secondary hemostatic
            tination. In each of these tests, antibodies against   disorder.
            the product of interest are bound to latex beads
            suspended in solution. When the product is present,
            the beads clump and fall out of solution, which is   Primary hemostatic disorders
            detected as decreasing turbidity of the sample.  Primary hemostatic disorders involve the platelets.
                                                         With primary  hemostatic disorders,  animals  will
                                                         bleed at gingival surfaces in the mouth or other
            Viscoelastic testing
                                                         mucosal surfaces such as the nose. They will also
            As blood clots, it goes from a liquid state to a more   display petechia or ecchymosis which is essentially
            solid ‘gel-like’ consistency. This physical change is   pinpoint or larger areas of bleeding under the skin
            the basis of viscoelastic testing methodologies such   (Fig. 9.10). Other common areas to find bleeding
            as thromboelastography (TEG) or rotational throm-  are  in  the  bladder leading  to  hematuria,  within
            boelastometry (ROTEM). Rather than measuring   the anterior chamber of the eye causing hyphema
            specific cell or protein activities as in previous tests,   (Fig. 9.11), or in the gastrointestinal (GI) tract
            these assays examine how the mechanical proper-  causing melena.
            ties of the  sample change over time  as a way to   Primary hemostatic disorders can be divided
            assess overall clot kinetics and strength.  This   into  two large categories – thrombocytopenia or


             188                                                         E.J. Thomovsky and A.C. Brooks
   191   192   193   194   195   196   197   198   199   200   201